Rose Jeffrey Matthew bought MED
May 26, 2026 · Form 4 insider transaction
Rose Jeffrey Matthew bought 11,680 shares of Medifast, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
11,680
Price
$0.00
Total value
N/A
InsiderRose Jeffrey Matthew
Role—
CompanyMedifast, Inc. (MED)
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateMay 26, 2026
Filing dateMay 28, 2026
Shares owned after11,680
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
These restricted stock units were granted under the Medifast, Inc. Director's Deferred Compensation Plan, as Amended and Restated (the "Plan"), in connection with the payment of the reporting person's annual director fees. Each unit represents the right to receive one share of the Issuer's common stock. These shares are granted from the Issuer's Amended and Restated 2012 Share Incentive Plan and will vest in full on May 26, 2027.